Jaguar Health (JAGX) Revenue & Revenue Breakdown
Jaguar Health Revenue Highlights
Latest Revenue (Y)
$9.76M
Latest Revenue (Q)
$2.72M
Main Segment (Y)
Mytesi
Jaguar Health Revenue by Period
Jaguar Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $9.76M | -18.36% |
| 2022-12-31 | $11.96M | 175.80% |
| 2021-12-31 | $4.33M | -53.81% |
| 2020-12-31 | $9.38M | 62.50% |
| 2019-12-31 | $5.78M | 30.78% |
| 2018-12-31 | $4.42M | 1.26% |
| 2017-12-31 | $4.36M | 2981.61% |
| 2016-12-31 | $141.52K | -45.23% |
| 2015-12-31 | $258.38K | 100.00% |
| 2014-12-31 | - | - |
Jaguar Health generated $9.76M in revenue during NA 2023, up -18.36% compared to the previous quarter, and up 221.03% compared to the same period a year ago.
Jaguar Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $2.72M | 15.74% |
| 2024-03-31 | $2.35M | 2.22% |
| 2023-12-31 | $2.30M | -18.24% |
| 2023-09-30 | $2.81M | 5.12% |
| 2023-06-30 | $2.68M | 35.70% |
| 2023-03-31 | $1.97M | -39.51% |
| 2022-12-31 | $3.26M | 3.49% |
| 2022-09-30 | $3.15M | 7.84% |
| 2022-06-30 | $2.92M | 11.28% |
| 2022-03-31 | $2.63M | 26.20% |
| 2021-12-31 | $2.08M | 230.16% |
| 2021-09-30 | $630.00K | 63.64% |
| 2021-06-30 | $385.00K | -68.98% |
| 2021-03-31 | $1.24M | -51.82% |
| 2020-12-31 | $2.58M | -7.10% |
| 2020-09-30 | $2.77M | -12.44% |
| 2020-06-30 | $3.17M | 264.44% |
| 2020-03-31 | $869.00K | -42.34% |
| 2019-12-31 | $1.51M | 54.92% |
| 2019-09-30 | $972.78K | -42.97% |
| 2019-06-30 | $1.71M | 7.29% |
| 2019-03-31 | $1.59M | -0.38% |
| 2018-12-31 | $1.60M | 40.97% |
| 2018-09-30 | $1.13M | 28.08% |
| 2018-06-30 | $883.85K | 9.88% |
| 2018-03-31 | $804.36K | -47.84% |
| 2017-12-31 | $1.54M | 40.16% |
| 2017-09-30 | $1.10M | 22.72% |
| 2017-06-30 | $896.52K | 9.01% |
| 2017-03-31 | $822.41K | 2747.98% |
| 2016-12-31 | $28.88K | -42.66% |
| 2016-09-30 | $50.36K | 108.58% |
| 2016-06-30 | $24.14K | -36.71% |
| 2016-03-31 | $38.15K | -30.88% |
| 2015-12-31 | $55.19K | -28.94% |
| 2015-09-30 | $77.67K | 23.00% |
| 2015-06-30 | $63.14K | 1.21% |
| 2015-03-31 | $62.39K | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | - |
Jaguar Health generated $2.72M in revenue during Q2 2024, up 15.74% compared to the previous quarter, and up 137.98% compared to the same period a year ago.
Jaguar Health Revenue Breakdown
Jaguar Health Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Mytesi | $9.60M | $11.70M | $3.30M | $9.30M | $5.67M |
| Neonorm | $42.00K | $48.00K | $62.00K | $76.00K | $102.19K |
Jaguar Health's latest annual revenue breakdown by segment (product or service), as of Dec 23: Mytesi (99.56%), and Neonorm (0.44%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neonorm | $9.00K | $24.00K | $18.00K | $8.00K | $5.00K | $15.00K | $20.00K | $8.00K | $15.00K | $6.00K | $33.00K | $15.00K | $13.00K | $14.00K | $34.00K | $18.89K | $15.72K | $20.96K | $46.61K | - |
| Mytesi | $2.30M | $6.60M | $2.60M | $404.00K | $3.20M | $3.10M | $384.00K | $438.00K | $1.50M | $406.00K | $317.00K | $729.00K | $2.60M | $2.80M | $3.15M | $835.00K | $1.49M | $957.06K | $1.68M | $1.54M |
Jaguar Health's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Mytesi (99.61%), and Neonorm (0.39%).
Jaguar Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ONTX | Traws Pharma | $226.00B | $56.00K |
| JAGX | Jaguar Health | $9.76M | $2.72M |
| VBIV | VBI Vaccines | $8.68M | $1.21M |
| TNXP | Tonix Pharmaceuticals | $7.77M | $2.21M |
| VXRT | Vaxart | $7.38M | $6.40M |
| OCGN | Ocugen | $6.04M | $1.14M |
| SONN | Sonnet BioTherapeutics | $147.81K | - |
| ZURA | Zura Bio | - | - |
| ATNF | 180 Life Sciences | - | - |
| GOVX | GeoVax Labs | - | - |
| PHIO | Phio Pharmaceuticals | - | - |
| ZVSA | ZyVersa Therapeutics | - | - |
| VIRI | Virios Therapeutics | - | - |
| EFTR | eFFECTOR Therapeutics | - | - |
| CDIO | Cardio Diagnostics | - | $7.87K |
| DFFN | CervoMed | - | - |
| ACST | Acasti Pharma | - | - |
JAGX Revenue FAQ
What is Jaguar Health’s yearly revenue?
Jaguar Health's yearly revenue for 2023 was $9.76M, representing a decrease of -18.36% compared to 2022. The company's yearly revenue for 2022 was $11.96M, representing an increase of 175.80% compared to 2021. JAGX's yearly revenue for 2021 was $4.34M, representing a decrease of -53.81% compared to 2020.
What is Jaguar Health’s quarterly revenue?
Jaguar Health's quarterly revenue for Q2 2024 was $2.72M, a 15.74% increase from the previous quarter (Q1 2024), and a 1.68% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $2.35M, a 2.22% increase from the previous quarter (Q4 2023), and a 19.22% increase year-over-year (Q1 2023). JAGX's quarterly revenue for Q4 2023 was $2.3M, a -18.24% decrease from the previous quarter (Q3 2023), and a -29.45% decrease year-over-year (Q4 2022).
What is Jaguar Health’s revenue growth rate?
Jaguar Health's revenue growth rate for the last 3 years (2021-2023) was 125.17%, and for the last 5 years (2019-2023) was 69.01%.
What are Jaguar Health’s revenue streams?
Jaguar Health's revenue streams in c 23 are Mytesi, and Neonorm. Mytesi generated $9.6M in revenue, accounting 99.56% of the company's total revenue, down -17.95% year-over-year. Neonorm generated $42K in revenue, accounting 0.44% of the company's total revenue, down -12.50% year-over-year.
What is Jaguar Health’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Jaguar Health was Mytesi. This segment made a revenue of $9.6M, representing 99.56% of the company's total revenue.